Sergei Gulnik

3.3k total citations
49 papers, 2.5k citations indexed

About

Sergei Gulnik is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Sergei Gulnik has authored 49 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 25 papers in Infectious Diseases and 17 papers in Virology. Recurrent topics in Sergei Gulnik's work include HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (17 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Sergei Gulnik is often cited by papers focused on HIV/AIDS drug development and treatment (25 papers), HIV Research and Treatment (17 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Sergei Gulnik collaborates with scholars based in United States, Germany and United Kingdom. Sergei Gulnik's co-authors include John W. Erickson, Talapady N. Bhat, Betty Yu, Eric T. Baldwin, Hiroaki Mitsuya, Elena Gustchina, Jack Collins, Leonid I. Suvorov, Angela Lee and Dong Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Molecular Biology.

In The Last Decade

Sergei Gulnik

48 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergei Gulnik United States	25	1.1k	1.1k	1.0k	336	324	49	2.5k
Akbar Ali United States	28	1.2k 1.1×	1.1k 1.0×	684 0.7×	364 1.1×	109 0.3×	53	2.6k
E. Lucile White United States	25	900 0.8×	1.0k 0.9×	446 0.4×	214 0.6×	170 0.5×	62	2.1k
Alla Gustchina United States	37	1.7k 1.5×	684 0.6×	694 0.7×	124 0.4×	172 0.5×	94	3.2k
Eric T. Baldwin United States	22	1.6k 1.4×	927 0.8×	869 0.9×	239 0.7×	51 0.2×	38	2.9k
Neşe Kurt Yılmaz United States	26	925 0.8×	883 0.8×	546 0.5×	329 1.0×	132 0.4×	71	2.0k
Arne Schön United States	34	1.6k 1.4×	1.1k 1.0×	1.3k 1.2×	231 0.7×	107 0.3×	77	3.5k
Jochen Bodem Germany	24	739 0.7×	632 0.6×	674 0.7×	127 0.4×	318 1.0×	68	2.2k
Torsten Unge Sweden	32	1.6k 1.4×	1.1k 1.0×	675 0.7×	181 0.5×	89 0.3×	82	2.9k
Simon Cocklin United States	28	942 0.8×	891 0.8×	829 0.8×	132 0.4×	56 0.2×	73	2.1k
María‐Jesús Pérez‐Pérez Spain	34	1.7k 1.5×	1.6k 1.4×	1.1k 1.1×	77 0.2×	235 0.7×	150	3.7k

Countries citing papers authored by Sergei Gulnik

Since Specialization

Citations

This map shows the geographic impact of Sergei Gulnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Gulnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Gulnik more than expected).

Fields of papers citing papers by Sergei Gulnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Gulnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Gulnik. The network helps show where Sergei Gulnik may publish in the future.

Co-authorship network of co-authors of Sergei Gulnik

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Gulnik. A scholar is included among the top collaborators of Sergei Gulnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Gulnik. Sergei Gulnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Civin, Curt I., Alison M. Skelley, Yu Chen, et al.. (2016). Automated leukocyte processing by microfluidic deterministic lateral displacement. Cytometry Part A. 89(12). 1073–1083. 45 indexed citations

Gulnik, Sergei & Michael A. Eissenstat. (2008). Approaches to the design of HIV protease inhibitors with improved resistance profiles. Current Opinion in HIV and AIDS. 3(6). 633–641. 16 indexed citations

Maes, Dominique, Javier López-Jaramillo, Betty Yu, et al.. (2004). Structural study of the type II 3-dehydroquinate dehydratase fromActinobacillus pleuropneumoniae. Acta Crystallographica Section D Biological Crystallography. 60(3). 463–471. 10 indexed citations

Asojo, Oluwatoyin A., Elena Afonina, Sergei Gulnik, et al.. (2002). Structures of Ser205 mutant plasmepsin II fromPlasmodium falciparumat 1.8 Å in complex with the inhibitors rs367 and rs370. Acta Crystallographica Section D Biological Crystallography. 58(12). 2001–2008. 66 indexed citations

Gulnik, Sergei, Elena Afonina, Elena Gustchina, et al.. (2002). Utility of (His)6 Tag for Purification and Refolding of Proplasmepsin-2 and Mutants with Altered Activation Properties. Protein Expression and Purification. 24(3). 412–419. 13 indexed citations

Pettit, Steve C., et al.. (2002). The Dimer Interfaces of Protease and Extra-Protease Domains Influence the Activation of Protease and the Specificity of GagPol Cleavage. Journal of Virology. 77(1). 366–374. 60 indexed citations

Gulnik, Sergei, et al.. (2000). HIV protease: Enzyme function and drug resistance. Vitamins and hormones. 58. 213–256. 36 indexed citations

Shao, Wei, Angela Lee, Sergei Gulnik, et al.. (2000). A novel putative transcription factor protein MYT2 that preferentially binds supercoiled DNA and induces DNA synthesis in quiescent cells. FEBS Letters. 473(3). 363–369. 2 indexed citations

Nijhuis, Monique, Rob Schuurman, Dorien de Jong, et al.. (1999). Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS. 13(17). 2349–2359. 305 indexed citations

10.

Martin, Stephen F., Michael C. Hillier, Barbara Mathä, et al.. (1998). Cyclopropane-Derived Peptidomimetics. Design, Synthesis, Evaluation, and Structure of Novel HIV-1 Protease Inhibitors. Journal of Medicinal Chemistry. 41(10). 1581–1597. 44 indexed citations

11.

Stauber, Roland H., et al.. (1998). Analysis of Intracellular Trafficking and Interactions of Cytoplasmic HIV-1 Rev Mutants in Living Cells. Virology. 251(1). 38–48. 49 indexed citations

12.

Xie, Dong, et al.. (1998). Thermodynamics and Proton Uptake for Pepstatin Binding to Retroviral and Eukaryotic Aspartic Proteases. Advances in experimental medicine and biology. 436. 381–386. 2 indexed citations

13.

Towler, Eric M., Sergei Gulnik, Talapady N. Bhat, et al.. (1998). Functional Characterization of the Protease of Human Endogenous Retrovirus, K10: Can It Complement HIV-1 Protease?. Biochemistry. 37(49). 17137–17144. 46 indexed citations

14.

Randad, Ramnarayan S., Lucyna Lubkowska, Michael A. Eissenstat, et al.. (1998). Unsymmetric nonpeptidic HIV protease inhibitors containing anthranilamide as a P2′ ligand. Bioorganic & Medicinal Chemistry Letters. 8(24). 3537–3542. 1 indexed citations

15.

Majer, Pavel, Jack Collins, Sergei Gulnik, & John W. Erickson. (1997). Structure‐based subsite specificity mapping of human cathepsin D using statine‐based inhibitors. Protein Science. 6(7). 1458–1466. 31 indexed citations

16.

Wilson, Sara Ivy, Lowri H. Phylip, John Mills, et al.. (1997). Escape mutants of HIV-1 proteinase: enzymic efficiency and susceptibility to inhibition. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1339(1). 113–125. 36 indexed citations

17.

Baldwin, Eric T., Talapady N. Bhat, Sergei Gulnik, et al.. (1995). Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine. Structure. 3(6). 581–590. 127 indexed citations

18.

Erickson, John W., Eric T. Baldwin, Talapady N. Bhat, & Sergei Gulnik. (1995). Structure of Human Cathepsin D: Comparison of Inhibitor Binding and Subdomain Displacement with other Aspartic Proteases. Advances in experimental medicine and biology. 362. 181–192. 6 indexed citations

19.

Randad, Ramnarayan S., Lucyna Lubkowska, A. Bujacz, et al.. (1995). Structure-based design of achiral anthranilamides as P2/P2′ surrogates for symmetry-based HIV protease inhibitors: design, synthesis, X-ray structure, enzyme inhibition and antiviral activity. Bioorganic & Medicinal Chemistry Letters. 5(21). 2557–2562. 4 indexed citations

20.

Tarasova, Nadya I., et al.. (1991). A New Type of Aspartic Proteinase Inhibitors with a Symmetric Structure. Advances in experimental medicine and biology. 306. 539–542. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact